Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRaG-1 for CD8+ Lymphocytopenia in Solid Tumors
NCT07258160Phase 2Recruiting
- Sponsor
- The Second Affiliated Hospital of Soochow University
- Start
- Dec 2025
- Primary completion
- Jul 2026
- Modality
- Cytokines & Interferons, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of pembrolizumab + sargramostim in lymphopenia, sponsored by The Second Affiliated Hospital of Soochow University. Started Dec 2025; status: recruiting.
02
Drugs
pembrolizumab + sargramostim
03
Conditions
lymphopenia
Beyond the preview
Go deeper on NCT07258160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07258160.